Small Molecule Outsourcing STREAM

  1. Integrating Early Development With Clinical Supply

    In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.

  2. Expanding The OSD Toolbox 10/3/2024

    This session is designed to provide practical solutions for enhancing bioavailability and scalability in pharmaceutical formulations.

  3. Challenges Of Moving A Bioconjugate Candidate From Clinic To Market

    Drug developers must successfully navigate the path to market, under the growing pressure of regulation and competition, and while carefully managing technical and financial risk.

  4. Cambrex Scientist Spotlight: Ross McLellan 1/29/2025

    Ross McLellan, Team Lead for Solid Form Screening in Edinburgh, UK, leads a team dedicated to complex solid form screening and materials characterization for Cambrex’s global client base.

  5. From Bench To Batch: Strategies For Scaling HPAPI Production

    Highly potent materials bring additional challenges to manufacturing processes. Examine considerations for optimizing HPAPI production methods to reduce risk and deliver therapies to patients with speed.

  6. Future Of Pharma Packaging: Trends, Tech, And Patient Solutions 9/25/2025

    Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.

  7. Combination Products: Navigating Regulatory Strategy, Design Verification 5/19/2025

    Delve into the intricacies of combination products and the regulatory expectations, including risk-based determination, evaluation, and documentation approaches for performance requirements.

  8. How To Deal With The Complexity Of Drugs In Clinical Development

    Discover how to advance new compounds with complex chemistry through each stage of development by refining processes to give fit-for-purpose manufacturability and yields.

  9. Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders

    Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.

  10. Nanoparticle Enabled Formulation And Drug Delivery Solutions

    Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.